Driehaus Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTI Consulting
FCN
|
+$54.3M |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$33M |
| 3 |
Flywire
FLYW
|
+$32.6M |
| 4 |
America Movil
AMX
|
+$31M |
| 5 |
FIVE9
FIVN
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$85.8M |
| 2 |
United Parks & Resorts
PRKS
|
+$64.2M |
| 3 |
Vale
VALE
|
+$56.2M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$46M |
| 5 |
Axcelis
ACLS
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.12% |
| 2 | Technology | 17.89% |
| 3 | Industrials | 14.18% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 8.51% |
Similar funds
Driehaus Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Driehaus Capital Management held 470 positions worth $6.17B, down 24% from $8.14B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Driehaus Capital Management withdrew a net $820M in Q2 2022, closing 118 positions and reducing 120 holdings. Its most notable exit was Infosys, an estimated $85.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Driehaus Capital Management opened a new position in FTI Consulting worth $59.5M.
- Driehaus Capital Management's largest Q2 2022 buy was FTI Consulting: 329,108 shares worth $59.5M.
- Driehaus Capital Management added most to Xenon Pharmaceuticals in Q2 2022, an estimated $33M increase.
- Driehaus Capital Management's biggest Q2 2022 reduction was Axcelis, cutting an estimated $45.1M.
- Driehaus Capital Management fully exited Infosys in Q2 2022, selling an estimated $85.8M.
- Driehaus Capital Management's ten largest holdings make up 18% of its $6.17B portfolio in Q2 2022.
- Driehaus Capital Management opened 92 new positions and closed 118 in Q2 2022.
- Driehaus Capital Management's portfolio value fell 24% quarter-over-quarter to $6.17B.
Based on Driehaus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.